CVS stock icon

CVS Health
CVS

$61.37
0.44%
 

About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Employees: 300,000

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 22 analysts
0
News positive %
of 59 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

2% more call options, than puts

Call options by funds: $1.49B | Put options by funds: $1.46B

0.43% less ownership

Funds ownership: 78.96% [Q4 2023] → 78.53% (-0.43%) [Q1 2024]

2% less capital invested

Capital invested by funds: $80.2B [Q4 2023] → $78.7B (-$1.54B) [Q1 2024]

5% less funds holding

Funds holding: 2,189 [Q4 2023] → 2,088 (-101) [Q1 2024]

26% less repeat investments, than reductions

Existing positions increased: 748 | Existing positions reduced: 1,006

41% less funds holding in top 10

Funds holding in top 10: 66 [Q4 2023] → 39 (-27) [Q1 2024]

45% less first-time investments, than exits

New positions opened: 124 | Existing positions closed: 225

Research analyst outlook

22 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$58
5%
downside
Avg. target
$73
20%
upside
High target
$94
53%
upside

22 analyst ratings

12 positive
55%
10 neutral
45%
negative
0%
Cantor Fitzgerald
Sarah James
5%downside
$58
Neutral
Reiterated
12 Jun 2024
JP Morgan
Lisa Gill
40%upside
$86
Overweight
Maintained
30 May 2024
Baird
Michael Ha
1%downside
$61
Neutral
Initiated
30 May 2024
Argus Research
Chris Graja
30%upside
$80
Buy
Maintained
8 May 2024
Wells Fargo
Stephen Baxter
2%downside
$60
Equal-Weight
Maintained
7 May 2024

Financial journalist opinion

Based on 59 articles about CVS published over the past 30 days